ARCHIVES

Wyden Asks Bristol For documentation To Prove That Taxol Price Is Not “Gouging” Taxpayers

This article is from The Cancer Letter archive.

Vol. 19 No. 05 | January 29, 1993

Download PDF Visit The Full Archive

Related Articles

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

NCAB May Determine Fate Of NCOG, Possibly Other Regional Groups; Simone Denies CCIRC Prejudice

May 8, 1981